From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Whether you are a pharma manufacturer launching your first product or a seasoned manufacturer looking to move processing platforms or automate your government pricing program, our Government Pricing solutions can provide you with comprehensive services and confidence that set you up for success with your ongoing commercial and government obligations.
IntegriChain is the leader in Government Pricing consulting and solutions, providing government program blueprinting and enrollment services, methodology and policy development, and configuration of all price types leading to ongoing calculations required for pricing compliance in the Medicaid, Medicare, Public Health Service (PHS), and Federal Supply Schedule (FSS) programs.
Our pharma Government Pricing solution is expertly designed with robust data cleansing and standardization, automated data load processes, and auditable control reports covering all price calculation details. Benefits include:
Our comprehensive services automate the harmonization of transactional, domain and contract data and apply customer-approved price methodologies and in-line reporting for accurate and timely submission to the Centers for Medicaid and Medicare Services (CMS), Department of Veterans Affairs (VA) and Department of Defense (DOD)/DOD and other involved parties. All standard price types are available out of the box including AMP, BPi/BPa, URA, ASP, PHS, NFAMP and FCP.
Our Government Pricing Experts provide industry-leading business consulting services for the Medicaid Drug Rebate Program (MDRP), 340B PHS, Medicare Part B, Medicare Part D Coverage Gap, and other Federal and State regulated programs. We offer insights on FSS Contracting including FSS Pricing, Contract Negotiation, Pre- and Post-Award Audits, and Contract Analysis. Whether you are a manufacturer launching your first product soon or a seasoned manufacturer looking to move processing platforms, our Operational Consulting group can provide you the comfort that all you are set up for success with your ongoing Commercial and Government obligations.
Solve government pricing complexities
Updates on US Territory Enrollment Updates, Puerto Rico Medicaid Drug Rebate Program Claims Administrator, TAA Compliance and its Relevance to FSS Agreements, and State Price Transparency Reporting Updates.
Read the Blog
In a complex industry landscape, including recent IRA legislation, state price transparency laws, and aggressive pharmacy benefit managers (PBMs) price protection language, taking a WAC price increase can have multiple impacts on a pharmaceutical manufacturer’s overall business, as well as their Gross-To-Net (GTN) processes.
